New hope for Hard-to-Treat TB: experimental drug combo enters human trials
Disease control
Recruiting now
This study tests a new medicine (JDB0131) combined with other drugs to treat a tough form of tuberculosis that doesn't respond to the usual antibiotic rifampin. About 60 adults with this drug-resistant TB will receive different treatment combinations for 8 weeks. The main goal is…
Phase: PHASE2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC